Dr. Stephen Tichenor currently works as the Associate Director of Safety Pharmacology for Charles River’s site in Reno, Nevada. His responsibilities include overseeing and reviewing the work of study directors running full range of GLP pharmacokinetic and toxicology studies.
Stephen first started as a research scientist that conducted, designed, and reported preclinical toxicology, safety pharmacology, and respiratory models from academic, biotech, and pharmaceutical companies. Since then, he took on roles of increasing responsibility, including Senior Research Scientist, Principal Research Scientist, and site leader for the cardiovascular safety pharmacology program. Dr. Tichenor is responsible for conducting, managing, interpreting, and reporting study data, as well as ensuring regulatory compliance for assigned preclinical studies.
Stephen received his PhD in cellular and molecular pharmacology and physiology from the University of Nevada, Reno, where his research focused on on smooth muscle pharmacology and cell signal transduction mechanisms. He is an active member of multiple professional societies, including the Society of Toxicology and Safety Pharmacology Society.